
Semaglutide’s Double Power for Weight Loss and Knee Pain
The study, Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis, explores the impact of weekly semaglutide injections. It focuses on weight loss and pain relief for people with obesity and knee osteoarthritis (OA)
Published

Tirzepatide: A Double Approach to Diabetes and Weight Loss
Tirzepatide is a groundbreaking therapy gaining attention for treating type 2 diabetes and obesity. Unlike traditional drugs that target one pathway, tirzepatide uses two hormones, GLP-1 and GIP, to achieve a fuller metabolic control.
Published
Categorized as Diabetes Care, GLP1 agonist, Insights from Dr. Tashko, Tirzepatide Patient Information, Weight Loss

